The Impact of “CYP2C9” and “VKORC1” Genetic Polymorphism Upon Warfarin Dose Requirements
Alaa Mohamed Azab Farag;
Abstract
Warfarin is the most common oral anticoagulant used. Its dose variability is associated with many factors, including age, race, dietary vitamin K intake, intercurrent illness, drug interactions and genetic variation.
The present study was conducted on 40
The present study was conducted on 40
Other data
| Title | The Impact of “CYP2C9” and “VKORC1” Genetic Polymorphism Upon Warfarin Dose Requirements | Other Titles | تأثير الاختلاف للأشكال الجينية لكل من “CYP2C9” و“VKORC1” على متطلبات العلاج بعقار الورفارين | Authors | Alaa Mohamed Azab Farag | Keywords | The Impact of “CYP2C9” and “VKORC1” Genetic Polymorphism Upon Warfarin Dose Requirements | Issue Date | 2010 | Description | Warfarin is the most common oral anticoagulant used. Its dose variability is associated with many factors, including age, race, dietary vitamin K intake, intercurrent illness, drug interactions and genetic variation. The present study was conducted on 40 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.